HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New daily shot could free patients from calcium pills
Disease control CompletedThis phase 3 trial tested a daily injection called TransCon PTH in 81 adults with hypoparathyroidism, a condition where the body lacks parathyroid hormone, causing low calcium levels. The goal was to see if the drug could bring calcium levels back to normal and allow patients to …
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE3 • Sponsor: Visen Pharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
Pump delivery may improve mineral balance in hypoparathyroidism patients
Disease control CompletedThis study tested whether delivering a synthetic parathyroid hormone (PTH 1-34) through an insulin pump works better than twice-daily injections for people with chronic hypoparathyroidism. The goal was to keep blood and urine calcium levels stable with fewer fluctuations. The tri…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New hormone shot could free patients from daily calcium pills
Disease control CompletedThis phase 3 trial tested a daily injection called TransCon PTH in 84 adults with hypoparathyroidism, a condition where the body lacks parathyroid hormone. For 26 weeks, some participants received the drug and others a placebo, without knowing which. The goal was to see if the dr…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New weekly shot could ease hypoparathyroidism treatment burden
Disease control CompletedThis study tested a new medicine called MBX 2109, given once a week as a shot, in 64 adults with hypoparathyroidism. The goal was to see if it could safely help patients reduce their daily calcium and vitamin D pills while keeping blood calcium levels normal. The trial compared t…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug helps patients ditch daily calcium pills in hypoparathyroidism study
Disease control CompletedThis study tested a new drug called palopegteriparatide in 90 adults with chronic hypoparathyroidism, a condition where the body doesn't make enough parathyroid hormone. The goal was to see if the drug could help patients stop taking daily calcium and vitamin D supplements. Resea…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Simple blood test after thyroid surgery may spare patients unnecessary worry
Diagnosis CompletedThis study looked at 300 patients who had their thyroid gland removed. Doctors wanted to see if measuring parathyroid hormone (PTH) right after surgery could reliably rule out hypoparathyroidism, a condition where calcium levels drop too low. The goal was to find a PTH cutoff val…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated May 26, 2026 06:10 UTC
-
Blue spray could save voices and parathyroid glands during thyroid surgery
Symptom relief CompletedThis study tested whether spraying a blue dye called methylene blue onto tissues during thyroid surgery helps surgeons better see and protect the nerve that controls the voice and the glands that regulate calcium. 136 adults with benign thyroid nodules took part. The goal was to …
Matched conditions: HYPOPARATHYROIDISM
Phase: NA • Sponsor: Services Hospital, Lahore • Aim: Symptom relief
Last updated May 26, 2026 05:49 UTC
-
Study probes what patients and doctors know about NATPARA risks
Knowledge-focused CompletedThis study surveyed 200 patients and doctors to check their understanding of the risks and safe use of NATPARA, a drug for hypoparathyroidism. Participants answered true/false questions online, by phone, or on paper. No study medicine was given. The goal was to see how well key s…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Shire • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC
-
New oral tablets for bone health tested against injections
Knowledge-focused CompletedThis early-stage study tested several new oral tablet versions of a bone-building hormone (hPTH(1-34)) in 45 healthy men aged 18-35. The goal was to see how well the body absorbs these new tablets compared to an existing oral tablet and a standard injection. The study focused on …
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE1 • Sponsor: Entera Bio Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC